Skip to content

PHARMTHEEK

Active Risk: not assessed
Private limited companyfounded 2025active for 1 yearRue Ferrer 2, 1480 Tubize, BelgiumKBO/BCE: BE 1021.745.738
Summary

PHARMTHEEK is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €41,535 and a net result of €21,535. Its solvency ranks better than 10% of 6,651 sector peers (NACE 64, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
PHARMTHEEKActive
Risk analysis ReportCompare

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
PHARMTHEEK
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
One provision in the deed

deed of 03-04-2025

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
Each director alone
Board ruleHow the board is made up, meets and takes decisions.
“Avec ou sans limitation durée, organe d’administration” (deed in French)

deed of 03-04-2025

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Nominatives, registre des actions nominatives” (deed in French)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Libre cession tout ou partie si société ne compte plus qu’un actionnaire” (deed in French)
Share issue ruleHow and by whom new shares can be issued.
“Courrier électronique,ou courrier ordinaire même jour si pas d’adresse électronique, au moins quinze jours dès ouverture” (deed in French)

deed of 03-04-2025

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
First Wednesday of May at 19:00

deed of 03-04-2025

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Article 25, en tout temps par décision assemblée générale délibérant formes prévues modifications statuts” (deed in French)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Article 26, dissolution pour quelque cause et à quelque moment” (deed in French)

deed of 03-04-2025

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Pouvoir d’administration, ceux que loi et statuts réservent à assemblée générale” (deed in French)
Other provision: “Rémunération des administrateurs, portée aux frais généraux indépendamment frais représentation, voyages et déplacements” (deed in French)
Other provision: “Attributions et rémunérations éventuelles par organe, gestion journalière” (deed in French)
Other provision: “Trois ans, contrôle de la société” (deed in French)
Other provision: “Assemblée générale par procédure écrite, sinon organe doit convoquer assemblée générale” (deed in French)
Other provision: “Administrateur ou défaut actionnaire présent détenant plus actions ou parité plus âgé, séances procès-verbaux” (deed in French)
Other provision: “Délibérations-assemblée générale, Article 20” (deed in French)
Other provision: “Bénéfice annuel net, répartition-réserves” (deed in French)
Other provision: “Préservation patrimoine-distributions-jetons, Article 24” (deed in French)
Liquidation distribution: “Article 27, apurement dettes charges frais liquidation ou consignation montants nécessaires” (deed in French)
Other provision: “Siège, communications sommations assignations significations valablement faites” (deed in French)
Other provision: “Compétence judiciaire, Article 29” (deed in French)
Other provision: “Droit commun-dispositions finales transitoires, Article 30” (deed in French)
5 more provisions in the deed, see the deed of 03-04-2025

deed of 03-04-2025

We would like to set cookies. That happens only with your consent. What we measure